Mucus polymer concentration and in vivo adaptation converge to define the antibiotic response of Pseudomonas aeruginosa during chronic lung infection.
Matthew A GreenwaldSuzanne L MeinigLucas M PlottCristian RocaMatthew G HiggsNicholas P VitkoMatthew R MarkovetzKaitlyn R RouillardJerome CarpenterMehmet KesimerDavid B HillJonathan C SchislerMatthew C WolfgangPublished in: bioRxiv : the preprint server for biology (2023)
model for therapeutic development.